Skip to main content
Download PDF

Blockage of mechanosensitive Piezo1 channel alleviates the severity of experimental malaria-associated acute lung injury

volume 17, Article number: 46 (2024) Cite this article

Abstract

Background

Malaria-associated acute lung injury (MA-ALI) is a well-recognized clinical complication of severe, complicated malaria that is partly driven by sequestrations of infected red blood cells (iRBCs) on lung postcapillary induced impaired blood flow. In earlier studies the mechanosensitive Piezo1 channel emerged as a regulator of mechanical stimuli, but the function and underlying mechanism of Piezo1 impacting MA-ALI severity via sensing the impaired pulmonary blood flow are still not fully elucidated. Thus, the present study aimed to explore the role of Piezo1 in the severity of murine MA-ALI.

Methods

Here, we utilized a widely accepted murine model of MA-ALI using C57BL/6 mice with Plasmodium berghei ANKA infection and then added a Piezo1 inhibitor (GsMTx4) to the model. The iRBC-stimulated Raw264.7 macrophages in vitro were also targeted with GsMTx4 to further explore the potential mechanism.

Results

Our data showed an elevation in the expression of Piezo1 and number of Piezo1+-CD68+ macrophages in lung tissues of the experimental MA-ALI mice. Compared to the infected control mice, the blockage of Piezo1 with GsMTx4 dramatically improved the survival rate but decreased body weight loss, peripheral blood parasitemia/lung parasite burden, experimental cerebral malaria incidence, total protein concentrations in bronchoalveolar lavage fluid, lung wet/dry weight ratio, vascular leakage, pathological damage, apoptosis and number of CD68+ and CD86+ macrophages in lung tissues. This was accompanied by a dramatic increase in the number of CD206+ macrophages (M2-like subtype), upregulation of anti-inflammatory cytokines (e.g. IL-4 and IL-10) and downregulation of pro-inflammatory cytokines (e.g. TNF-α and IL-1β). In addition, GsMTx4 treatment remarkably decreased pulmonary intracellular iron accumulation, protein level of 4-HNE (an activator of ferroptosis) and the number of CD68+-Piezo1+ and CD68+-4-HNE+ macrophages but significantly increased protein levels of GPX4 (an inhibitor of ferroptosis) in experimental MA-ALI mice. Similarly, in vitro study showed that the administration of GsMTx4 led to a remarkable elevation in the mRNA levels of CD206, IL-4, IL-10 and GPX-4 but to a substantial decline in CD86, TNF-α, IL-1β and 4-HNE in the iRBC-stimulated Raw264.7 cells.

Conclusions

Our findings indicated that blockage of Piezo1 with GsMTx4 alleviated the severity of experimental MA-ALI in mice partly by triggering pulmonary macrophage M2 polarization and subsequent anti-inflammatory responses but inhibited apoptosis and ferroptosis in lung tissue. Our data suggested that targeting Piezo1 in macrophages could be a promising therapeutic strategy for treating MA-ALI.

Graphical Abstract

Background

Malaria, which is caused by bites of female Anopheles mosquitoes carrying Plasmodium spp., is highly endemic in sub-Saharan Africa, Southeast Asia and South America and results in enormous economic losses in endemic areas [1]. Even after adequate therapeutic management (e.g. artemisinin-based combination therapy) and preventive strategies (e.g. indoor residual spraying and long-lasting insecticide-treated nets), malaria remains one of the most severe public health problems worldwide, affecting ~ 241 million individuals, and results in the deaths of ~ 627,000 people annually [1]. To achieve its life cycle, Plasmodium parasites successively invade and replicate in the human host’s liver cells and red blood cells (RBCs) and subsequently trigger liver damage and anemia. Malaria infections affect other organs (e.g. brain, kidney and lung) and lead to multiple organ-specific dysfunctions [e.g. cerebral malaria (CM), acute kidney injury and acute lung injury (ALI)] by inducing uncontrolled or excessive inflammatory responses. Malaria associated-ALI (MA-ALI), and its more severe form (malaria associated-acute respiratory distress syndrome, MA-ARDS), is a well-recognized and life-threatening complication of severe Plasmodium spp. infection that is usually characterized by excessive pulmonary inflammation, leukocyte recruitment, pulmonary edema and alveolar epithelial damage, ultimately resulting in respiratory failure and high morbidity and mortality rates [2]. Many clinical studies have demonstrated that about 20–30% of severe Plasmodium falciparum malaria patients experience MA-ALI, and 50–90% die, even after anti-malarial treatment has remarkably reduced parasitemia levels [3]. Accumulated studies have shown that sequestration of iRBCs and leukocytes on lung postcapillary venules, followed by impaired blood flow, endothelial cell dysfunction, macrophage recruitment and excessive pro-inflammatory responses, are key factors in the severity of MA-ALI [4, 5], yet its underlying pathogenetic mechanism is not well elucidated.

Piezo1, a newly identified non-selective mechanosensitive ion channel, is widely distributed in a variety of cells and organs (e.g. lungs, skin and kidneys) that rapidly sense multi-mechanical stimuli (e.g. changes in blood flow and blood pressure) and ultimately is involved in pathophysiological processes of numerous lung diseases [6]. It was reported that pulmonary mechanical status changes (e.g. impaired blood flow) were primarily triggered by sequestrations of iRBCs on lung postcapillary venules in both malaria patients with ALI and a murine model of MA-ALI [7], indicating that Piezo1 may be involved in the pathogenic process of MA-ALI via sensing impaired pulmonary blood flow. Previous works showed that human RBCs from African individuals carrying gain-of-function PIEZO1 allele (E756del) were dehydrated and could attenuate intracellular growth of P. falciparum strain in vitro, indicating that Piezo1 in RBCs had significant resistance against severe malaria [8, 9]. Similarly, an in vitro study showed that human RBC infection by P. falciparum strain invasion was efficiently suppressed by the pharmacological activation of Piezo1 with Yoda1 via RBC dehydration [10]. A growing body of evidence has shown that Piezo1 transduced mechanical force to myeloid cells (e.g. leukocytes, monocytes and macrophages) and served as a vital regulator of innate immune responses with implications for tumor immunity and pathogen infections [11, 12]. Of note, although the link between Piezo1 in RBCs and inhibition of Plasmodium parasite growth has been extensively investigated so far, no data on the outcome of Piezo1 regarding the severity of MA-ALI via meditating host immune cell (e.g. macrophage) function and immune responses have yet been described.

Pulmonary macrophages, which comprise alveolar and interstitial macrophages, are one of the most abundant and key innate immune cells in lung tissue and subsequently play a key role in the first-line defense against pathogens, tissue repair and immune regulation by phagocytosis and appropriate inflammatory responses [13]. Alternatively, pulmonary macrophage dysfunction can exacerbate lung injury in a variety of diseases, including MA-ALI [14]. Upon multiple stimuli, macrophages are usually polarized into two distinct subsets: (i) M1-like macrophages that produce massive pro-inflammatory cytokines and are closely linked to host defense against pathogens; (ii) M2-like macrophages that alternatively contribute to tissue repair by triggering an anti-inflammatory response. Accumulating evidence has demonstrated that macrophages play a conflicting role (e.g. as a protective or pathological factor) in response to malaria infections, including MA-ALI [15]. M1-like macrophages were prominent in lung tissues from severe P. falciparum malaria patients with pulmonary edema and served as a key factor in triggering lung pathology [5]. Alternatively, IL-33-mediated protection against experimental CM (ECM) was linked to induction of M2-like macrophages [16]. Conversely, pre-existing infection of Trichinella spiralis suppressed Plasmodium berghei parasitemia but aggravated malaria-induced liver pathology partly by stimulating M2 macrophages [17]. Higher expression of CD11b and HIF-1α in pulmonary macrophages plays a central role in mediating alveolar-endothelial barrier disruption, which ultimately leads to lung injury in malaria patients with ALI [18]; in other work, alveolar macrophages were conversely proposed as a protective agent in response to malaria infection, since the anti-CD11b treatment diminished monocyte homing and decreased parasite elimination in the lung tissues [19]. Based on these findings, the trend and severity of MA-ALI may be determined by the imbalance of pulmonary M1/M2 macrophages, and it is suggested that the control of macrophage M1/M2 polarization may be expected to improve the severity of MA-ALI. Currently, several studies have demonstrated that Piezo1 is highly expressed in macrophages and involved in modulating immune functional response of macrophages, including M1/M2 polarization [20, 21]. A further report indicates the role of perivascular macrophages as regulators of blood flow following tissue damage [22]. Given that impaired blood flow induced by sequestration of iRBCs on lung postcapillary venules was commonly observed in lung tissue of malaria patients with ALI and experimental MA-ALI mice, these findings raise an intriguing possibility that Piezo1 in macrophages could mediate the severity of MA-ALI by sensing impaired pulmonary blood flow. So far, its mechanism is unknown.

Because of limitations in accessing lung tissues from malaria patients with ALI, a murine model of C57BL/6 mice with P. berghei ANKA strain infection has usually been adopted to explore the pathogenesis of MA-ALI; this model exhibited various similarities of syndromes in malaria patients with ALI, including iRBC sequestration on lung postcapillary venules, pulmonary edema and hemorrhage [23]. Herein, this study administered a Piezo1 inhibitor (GsMTx4) to experimental MA-ALI mice by using C57BL/6 mice with P. berghei ANKA infection to investigate the function of Piezo1 in the pathogenesis of MA-ALI. iRBC-stimulated mouse Raw264.7 macrophage cells were also targeted with GsMTx4 to further explore the potential mechanism. Using in vivo and in vitro assays, our findings demonstrated that blockage of Piezo1 with GsMTx4 dramatically triggered pulmonary macrophage M2 polarization and subsequent anti-inflammatory responses, but suppressed apoptosis and ferroptosis, which in turn alleviated the severity of MA-ALI. Our findings could update the current understanding of the link between Piezo1 and severity of MA-ALI, and we propose that blocking Piezo1 in macrophages may be a valuable therapeutic approach for treating MA-ALI.

Methods

Mice and ethics statement

Female C57BL/6 mice (6 weeks old, weighing ~ 20 g) were purchased from Guangdong Medical Experimental Animal Center and bred in a specific pathogen-free (SPF) facility with free access to food/water as well as a standard 12-h light/dark cycles in the Experimental Animal Center of Guangdong Pharmaceutical University, China. Plasmodium berghei ANKA-iRBCs (kindly donated by Prof. Jianping Song, Guangzhou University of Chinese Medicine, China) were stored in our laboratory's − 80 °C freezer and kept by regular passage in donor mice with intraperitoneal (i.p.) injection. All animal experiments were conducted following the National Guidelines for the Care and Use of Animals and approved by the Ethics Committee of Guangdong Pharmaceutical University (no. gdpulac2023001).

Blockage of Piezo1 with GsMTx4 in the P. berghei ANKA-infected mice

Sixty-eight mice were randomly separated into four different groups, including Naive (n = 14), GsMTx4 (n = 14), Pb (n = 20) and Pb + GsMTx4 (n = 20) groups. In the Naive and GsMTx4 groups, each animal was i.p. injected daily with only 100 μl PBS or 1.0 mg/kg GsMTx4-a inhibitor of Piezo1 (no. HY-P1410, Med Chem Express, China) diluted in the same volume of PBS. In the Pb and Pb + GsMTx4 groups, each infected animal, which had been i.p. mono-infected with 1.0 × 106 P. berghei ANKA-iRBCs, received daily i.p. injection of 100 μl PBS or 1.0 mg/kg GsMTx4 diluted in the same volume of PBS starting from day 1 post infection (p.i.) until the day the animal was killed. Once the P. berghei ANKA-infected mice exhibited signs of neurological impairment (e.g. paralysis, convulsions, coma and loss of reflex), being usually moribund at 7–11 days p.i., these animals were considered ECM mice. Body weight, survival rate and ECM incidence were monitored daily. Peripheral parasitemia was determined daily using Giemsa-stained thin blood smears from days 3 p.i. to 18 p.i. and calculated as 100% × iRBCs/total RBCs.

Bronchoalveolar lavage fluid (BALF) and histopathology analyses

Since increased total protein of BALF is usually used as a biomarker for the onset of MA-ALI, mouse BALF was collected and total protein concentrations were determined as described previously [4]. Briefly, at each examination point (at 7 and 14 days p.i.), animals were randomly selected and killed by inhalation of isoflurane (n = 4–5/group). BALF was obtained by instilling and aspirating the lungs with 1.0 ml ice-cold PBS; then, it was centrifuged at 1000 g at 4 °C for 10 min. The BALF supernatant was harvested and stored at − 80 °C until usage. The total protein concentrations of BALF were ultimately measured using a bicinchoninic acid protein assay kit (Beyotime, China).

At 7 and 14 days p.i., animals (n = 4–5/group) were also randomly selected and killed to assess histopathological lung changes using hematoxylin and eosin (H&E) staining. The harvested lung was immediately fixed in 10% buffered formalin for 48 h, dehydrated with xylene, cleared with ethanol, embedded in paraffin and then sliced into 5-μm-thick non-sequential sections. Three non-contiguous lung slices from each animal (n = 4–5/group) were successively deparaffinized with xylene, rehydrated with ethanol solutions and then stained with H&E dye. More than 20 fields per lung slice were randomly selected for evaluation under a Leica DM 2500B microscope at a magnification of × 400 by two blinded pathologists. Semi-quantitative histopathological lung scores, which were determined by seven parameters (alveolar hemorrhage and congestion, alveolar edema, formation of hyaline membranes, thickening of alveolar septa, intra-alveolar inflammation, interstitial inflammation and thrombus formation), were obtained to evaluate lung inflammation and injury as described previously [24]. The score of each parameter ranged from 0 to 3 as follows: 0 = absent; 1 = mild; 2 = moderate; 3 = severe. The total score of lung histopathological change was calculated as the sum of the scores for each parameter; the highest possible score was 21.

Determination of lung wet/dry weight ratio

Since lung wet/dry weight ratio commonly serves as an indicator of pulmonary edema, animals (n = 4–5/group) were randomly selected and killed to measure this ratio at 7 or 14 days p.i. Briefly, the freshly harvested right lung was immediately wiped dry using filter paper and weighed using an electronic balance. Subsequently, the lung tissue was dried in an incubator at 80 °C for 2 days and weighed again. The lung wet/dry weight ratio was calculated to evaluate the degree of pulmonary edema.

Evaluation of lung vascular leakage

Since pulmonary vascular leakage is a hallmark of onset of MA-ALI, Evans blue staining was used to evaluate lung vascular leakage in MA-ALI mice upon GsMTx4 treatment. At 7 or 14 days p.i., 4–5 mice/group were killed by inhalation of isoflurane and then i.v. injected with 100 μl of 2% Evans blue dye for 30 min. Lungs were immediately harvested, weighted and placed in 2.0 ml formamide at 37 °C for 48 h to extract Evans blue dye from the tissue. After centrifugation at 1000 g at 4 °C for 10 min, the absorbance of Evans blue in supernatant was measured at λ = 620 nm using a microplate reader. Lung permeability was calculated referring to standard curves and indicated as micrograms of Evans Blue per gram of lung weight.

TUNEL assay

TUNEL-DAPI double staining was performed to evaluate lung apoptotic changes in the experimental MA-ALI mice upon GsMTx4 treatment following the manufacturer’s instructions (no. G1501-50 T; Servicebio). Briefly, three non-contiguous lung slices from each animal (n = 4–5/group) were deparaffinized with xylene, rehydrated with graded ethanol solutions and subsequently incubated with 20 mg/ml of proteinase K at 37 °C for 30 min. After rinsing with distilled water, the slices were immersed in TUNEL reaction mixture (CY5-biotinylated dUTP in TdT buffer) at 37 °C for 60 min, restained with 1 μg/ml of DAPI solution at 37 °C for 10 min, coverslipped with anti-fade polyvinylpyrrolidone solution (Beyotime, China) and then examined under a fluorescence microscope. Fluorescent images of TUNEL-positive apoptotic cells with green color and cell nuclei with blue color were captured using a Leica DM 2500B microscope at × 200 magnification. The apoptosis index was determined as apoptosis-positive number/field from more than 20 random fields per lung section (n = 4–5 mice/group).

Iron state in lung tissue using Perl's Prussian blue staining

To explore the effect of GsMTx4 treatment on iron state in lung tissue of the experimental MA-ALI mice, Perl's Prussian blue staining was carried out using an Iron Stain Kit based on the manufacturer’s instructions (no. G1029-100ML; Servicebio). Briefly, three non-contiguous lung slices from each animal (n = 4–5/group) were successively deparaffinized with xylene, rehydrated with a graded ethanol solution and subsequently cultured in a freshly prepared mixture of 5% potassium ferrocyanide and 5% hydrochloric acid for 30 min. After rinsing with double-distilled water, the slides were immersed in 2% pararosaniline solution for 5 min and sealed with neutral gum. The positively stained cells were shown by blue staining and captured using a Leica DM 2500B light microscope at × 400 magnification. The integrated optical density (IOD)/area of positive Perl's Prussian blue-stained cells was calculated in > 20 random fields per lung section (n = 4–5 mice/group).

Immunohistochemistry of CD68, CD86, CD206, GPX4, 4-HNE and Piezo1 in lung

To assess the effect of GsMTx4 treatment on lung macrophage M1/M2 polarizations and ferroptosis in the experimental MA-ALI mice, immunohistochemical analysis for CD68 (a marker for all macrophages), CD86 (a marker for M1-like macrophages), CD206 (a marker for M2-like macrophages), GPX4 (an inhibitor of ferroptosis), 4-HNE (4-hydroxynonenal, an activator of ferroptosis) and Piezo1 in lung tissue across different groups was performed. Briefly, three non-contiguous lung slices from each animal (n = 4–5/group) were sequentially deparaffinized with xylene, rehydrated with a graded ethanol series, boiled in a microwave with sodium citrate buffer (pH 6.0) at 95 °C for 10 min for retrieval antigens and subsequently cultured with 3% hydrogen peroxide to remove endogenous peroxidase. To avoid non-specific binding, the slides were immersed in normal serum at 37 ℃ for 30 min. Following three washes with PBS, slices were sequentially incubated with primary antibodies [monoclonal rabbit anti-CD68 antibody (1:200 dilutions; no. 97778S; CST); monoclonal rabbit anti-CD86 antibody (1:200 dilutions; no. 19589S; CST); polyclonal rabbit anti-CD206 antibody (1:400 dilutions; no. GB113497-100; Servicebio); polyclonal rabbit anti-GPX4 antibody (1:100 dilutions; no. DF6701; Affinity); monoclonal mouse anti-4-HNE antibody (1:200 dilutions; no. ab48506; Abcam); or monoclonal mouse anti-Piezo1 antibody (1:200 dilutions; no. MA5-32876; Invitrogen)] followed by co-culture with secondary antibody [goat anti-rabbit IgG (H + L) HRP (1:200 dilutions; no. S0001; Affinity) or goat anti-mouse IgG HRP (1:200 dilutions; no. 8125P; CST)] at 37 ℃ for 45 min, respectively. Finally, the slides were overlaid with horseradish peroxidase (HRP)-conjugated secondary antibody (1:1000 dilution), covered with freshly prepared hematoxylin and captured using a Leica DM 2500B light microscope at × 200 and × 400 magnification. Positively stained cells were shown by dark-brown staining. The number of positively stained CD68, CD86 and CD206 cells/field in lung was calculated from > 20 random fields per lung section from each animal (n = 4–5/group), while IOD/area was examined to assess the level of positive expression of GPX4, 4-HNE and Piezo1.

Immunofluorescence Double Staining for CD68+-Piezo1+ and CD68+-4-HNE+ pulmonary macrophages

To explore the effect of GsMTx4 treatment on expression of Piezo1 and 4-HNE on pulmonary CD68+ macrophages in experimental MA-ALI mice, double immunofluorescence staining of CD68+-Peizo1+ macrophages and CD68+-4-HNE+ macrophages was performed as described previously [25]. Briefly, after being deparaffinized with xylene and rehydrated with a graded ethanol series, three non-contiguous lung slices from each animal (n = 4–5/group) were immersed in 10 mM sodium citrate buffer (pH 6.0) at 95 °C for 10 min for antigen retrieval and cultured with 3% H2O2 for 5 min to eliminate endogenous peroxidase activity. After rinsing with PBS, slides were blocked with 10% normal serum at 37 °C for 30 min, incubated with monoclonal rabbit anti-CD68 antibody (1:200 dilutions; no. 97778S; CST) and monoclonal mouse anti-Piezo1 antibody (1:200 dilutions; no. MA5-32,876; Invitrogen) or monoclonal mouse anti-4-HNE antibody (1:200 dilutions; no. ab48506; Abcam) at 4 °C overnight, followed by incubation with two different kinds of secondary antibody [Alexa Fluor R488 Conjugate anti-rabbit IgG, (1:400 dilution; no. 4412S; CST) and Alexa Fluor R594 anti-mouse IgG (1:1000 dilution; no. 8890S; CST)] at 37 °C for 1 h in darkness. After washing with PBS, the slices were stained with DAPI for 5 min for dying cell nuclei, mounted using anti-fade polyvinylpyrrolidone solution (Beyotime, China) and imaged under a Leica DM 2500B light microscope at ×200 magnification. The positively stained CD68 cells appeared green, whereas positively stained Piezo1 and 4-HNE cells exhibited red fluorescence. Positively stained double CD68+-Piezo1+ and CD68+-4-HNE+ cells showed yellow fluorescence. The number of positively stained CD68+-Piezo1+ and CD68+-4-HNE+ cells per field was calculated from > 20 random lung fields for each animal (n = 4–5/group).

In vitro experiment of iRBC-stimulated murine RAW264.7 macrophages subjected to GsMTx4 treatment

The murine macrophage cell line (RAW264.7) was acquired from Stem Cell Bank (Chinese Academy of Sciences, China) and cultured in DMEM medium consisting of 10% FBS (no. 26010074#, Gibco™) and 1% penicillin/streptomycin at 37 °C with 5% CO2 atmosphere. RAW264.7 cells were plated at a density of 2 × 105 cells/ml in six-well plates and pretreated with Piezo1 inhibitor GsMTx4 (5 μM) for 1 h, followed by co-culture with 5.0 × 106 iRBC/well for 24 h and 48 h. RAW264.7 cells treated with only PBS served as a blank group. After rinsing with ice-cold PBS buffer, the harvested pellets of RAW264.7 cells were stored in Trizol reagent (no. 9109#, TaKaRa) at − 80 °C until usage. This experiment was independently repeated five times.

qPCR assay

Total RNA was extracted from in vitro RAW264.7 cells and in vivo lung tissues across different groups utilizing Trizol reagent (no. 9109, TaKaRa) and subsequently reverse-transcribed into cDNA using PrimeScriptTM 1st Strand cDNA Synthesis Kit (no. 6210B, TaKaRa), following the manufacturer’s protocols. The primers were designed and provided by Sangon Biotech (Shanghai, China) and are listed in Additional file 1: Table S1, including CD86, CD206, TNF-α, IL-1β, IL-4, IL-10, GPX4, 4-HNE and P. berghei ANKA 18S rRNA. The expression of target genes was determined using SYBR Green qPCR Master Mix (no. 6110B, TaKaRa, Japan), normalized to GAPDH and calculated by using the 2−ΔΔCt method. The qPCR reaction mixture contained 5.0 µl of SYBR R Premix ExTaq TM (2 ×), 0.5 µl of each primer (10 pM), 3.0 µl of dH2O and 1.0 µl of preamplified cDNA (100 ng/µl). The amplification conditions were as follows: 95 °C for 5 min; 40 amplification cycles (95 °C for 5 s and 60 °C for 20 s).

Statistical analysis

GraphPad Prism 5.0 software was used for statistical analyses, and data were expressed as mean ± SD. The differences between two groups were analyzed by independent sample t-test, whereas the differences among multiple groups were checked by one-way ANOVA test. A time series analysis test or log-rank test was carried out to compare discrepancies in body weight, parasitemia and survival time of mice accross different groups, respectively. P < 0.05 was taken as significant difference.

Results

GsMTx4 treatment prolonged host survival rate but decreased body weight loss, ECM incidence and parasite burden in the P. berghei ANKA-infected mice

To explore the effect of blockage of Piezo1 with GsMTx4 on morbidity and mortality in P. berghei ANKA-infected mice, disease signs (e.g. body weight, ECM incidence, survival time and parasite burden) were monitored daily in mice across different groups. No significant changes or small elevations of 3–6% in body weight from the initial body weight were detected in Naive and GsMTx4 group over the 18 days of observation, whereas the infected mice in Pb and Pb + GsMTx4 groups lost body weight at 5–18 days p.i. (Fig. 1A). Notably, the infected control mice exhibited ~ 15% and ~ 22% loss relative to the initial body weight at 7 and 14 days p.i., respectively, whereas animals in the Pb + GsMTx4 group showed a lower body weight loss than those in the Pb group (~ 9% vs. ~ 15% at 7 days p.i., P < 0.05; ~ 16% vs. ~ 22% at 14 days p.i., P < 0.05). As shown in Fig. 1B, the infected control mice in Pb group died within 8–18 days p.i., during which ~ 65% of them developed into ECM mice. In contrast, the infected mice with GsMTx4 treatment survived longer and showed a lower ECM incidence (~ 50% vs. ~ 65%, P < 0.05) than those in the Pb group, resulting in a significant difference in survival curves of mice between Pb and Pb + GsMTx4 groups (P = 0.0032). As shown in Fig. 1C, a lower peripheral blood parasitemia at 5–18 days p.i. was observed in the infected mice in Pb + GsMTx4 group compared with those in Pb group (P < 0.05). Consistent with trends in peripheral blood parasitemia, there was a significant decline in lung parasite burden at 7 and 14 days p.i. (P < 0.01) in the infected mice treated with GsMTx4 compared to the infected control mice, as determined by measuring the level of P. berghei ANKA 18S rRNA with qRT-PCR assay (Fig. 1D). Thus, our results indicated that blockage of Piezo1 with GsMTx4 remarkably prolonged the survival rate but decreased peripheral parasitemia/lung tissue parasite burden and ECM incidence in response to P. berghei ANKA infection.

Fig. 1
figure 1

Changes in body weight, survival rate, peripheral blood parasitemia and lung parasite burden in Plasmodium berghei ANKA-infected mice upon GsMTx4 treatment. A, B Average body weight and survival rate were monitored daily in mice across different groups over the 18 days of observation. A time series analysis test and log-rank test was conducted to compare discrepancies in body weight or survival rate of mice, respectively. C Peripheral blood parasitemia was determined daily by Giemsa-stained thin blood smears in the infected mice in Pb and Pb + GsMTx4 groups. A time series analysis test was used to compare the significance of differences in parasitemia of mice. D Estimation of lung parasite burden at 7 and 14 days p.i. by quantifying the mRNA levels of P. berghei ANKA 18S rRNA using qPCR assay and 2−ΔΔCt method. #P < 0.05 and ##P < 0.01 vs. infected control mice at 7 days p.i.; &P < 0.05 and &&P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment alleviated lung damage and apoptosis in the murine model of MA-ALI

To assess the effect of GsMTx4 on the severity of MA-ALI, multiple MA-ALI determinants, including total protein concentrations in BALF, lung wet/dry weight ratio and lung vascular leakage, were analyzed across different groups. As shown in Fig. 2, GsMTx4 treatment did not notably alter these three MA-ALI determinants in the uninfected mice compared with naive mice (P > 0.05). However, there was a significant elevation in total protein concentrations in BALF, lung wet/dry weight ratio and lung vascular leakage in the infected control mice (Pb group) at 7 and 14 days p.i. compared to those in the naive group (P < 0.01), indicating the successful establishment of a murine model of MA-ALI in C57BL/6 mice with P. berghei ANKA infection. Moreover, the elevated levels of total protein concentrations in BALF (P < 0.05 or P < 0.01), lung wet/dry weight ratio (P < 0.05) and lung vascular leakage (P < 0.05) were remarkably suppressed by GsMTx4 in the infected mice at 7 or 14 days p.i. in Pb + GsMTx4 group when compared with Pb group.

Fig. 2
figure 2

Changes in total protein in BALF, lung wet/dry weight ratio and pulmonary vascular leakage in Plasmodium berghei ANKA-infected mice upon GsMTx4 treatment. Four to five mice were randomly selected for analysis at 7 or 14 days p.i. A Total protein concentration in BALF according to BCA protein assay. B Lung wet weight/dry (W/D) weight ratio. C Pulmonary vascular leakage by Evan blue staining. The differences between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

Subsequently, H&E staining was performed to identify pathological changes in the lung in the experimental MA-ALI mice following GsMTx4 treatment. As shown in Fig. 3A, no obvious morphological abnormality or pathological change was observed in lung tissue in the Naive or GsMTx4 group. Following infection at 7 or 14 days p.i., animals in Pb group contrarily revealed massive iRBCs in interalveolar spaces, thickened alveolar walls, obvious inflammatory cell infiltration, thrombus, pulmonary hemorrhage and edema in lung tissues, whereas these histopathological indicators were remarkably improved by GsMTx4 treatment in the infected mice in Pb + GsMTx4 group. In addition, a semi-quantitative score analysis further showed a significant reduction in lung histopathological scores in the GsMTx4-treated infected mice at 7 (P < 0.01) and 14 days p.i. (P < 0.05) compared to Pb group, respectively (Fig. 3B). Taken together, our results suggested that blockage of Piezo1 with GsMTx4 largely ameliorated pathological injury of the lung in experimental MA-ALI mice.

Fig. 3
figure 3

Changes in pulmonary histopathological damage in experimental MA-ALI mice upon GsMTx4 treatment. B Representative figures of pulmonary histopathological damage in mice across different groups using H&E staining under a light microscope at 400 × magnification. Naive mice a; GsMTx4-treated uninfected mice b; Plasmodium berghei ANKA-infected control mice at 7 days p.i. c; GsMTx4-treated infected mice at 7 days p.i. d; P. berghei ANKA infected-control mice at 14 days p.i. e; GsMTx4-treated infected mice at 14 days p.i. f. B Analysis of pulmonary histopathology scores. The differences in histopathology scores between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

Next, a TUNEL assay was performed to evaluate lung apoptosis change in the experimental MA-ALI mice upon GsMTx4 treatment. As shown in Fig. 4, rare TUNEL-positive stained cells were detected in the lung tissues in Naive and GsMTx4 groups. However, a substantial increase of pulmonary apoptotic cells/field was observed in the infected mice in Pb group compared to Naive group (P < 0.05). In contrast, a marked decline in pulmonary apoptotic cells/field was observed in Pb + GsMTx4 group at 7 and 14 days p.i. compared to those of Pb group (P < 0.01). These data indicated that the extensive pulmonary cellular apoptosis was significantly inhibited by GsMTx4 treatment in experimental MA-ALI mice.

Fig. 4
figure 4

Changes in pulmonary cellular apoptosis in the experimental MA-ALI mice upon GsMTx4 treatment. A Representative figures of pulmonary cellular apoptosis in mice across different groups using TUNEL staining. Naive mice a; GsMTx4-treated uninfected mice b; Plasmodium berghei ANKA-infected control mice at 7 days p.i. c; GsMTx4-treated infected mice at 7 days p.i. d; P. berghei ANKA infected control mice at 14 days p.i. e; GsMTx4-treated infected mice at 14 days p.i. f. Positive apoptotic cells are illustrated by green fluorescence (arrows) and captured by fluorescence microscopy at 200 × magnification. B Apoptosis index is determined as positive apoptotic cells/field by counting in > 20 random lung fields per animal (n = 4–5/group). The differences in pulmonary apoptotic cells/field between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; & P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment promoted pulmonary anti-inflammatory response in the murine model of MA-ALI

We also assessed the changes in pulmonary inflammatory response in the experimental MA-ALI mice upon GsMTx4 treatment using a qPCR assay. As shown in Fig. 5, no significant change in the mRNA levels of all evaluated cytokines (e.g. TNF-α, IL-1β, IL-4, and IL-10) was observed in lung tissues between Naive and GsMTx4 groups (P > 0.05). However, increased mRNA levels of all evaluated cytokines were observed in lung tissues of PbA-infected control mice at 7 and 14 days p.i. (P < 0.01). Notably, there was a dramatical elevation in the mRNA levels of anti-inflammatory cytokines [e.g. IL-4 (P < 0.05) and IL-10 (P < 0.01)] but a remarkable decrease of pro-inflammatory cytokines [e.g. TNF-α (P < 0.05) and IL-1β (P < 0.01)] in lung tissues in Pb + GsMTx4 group at 7 and 14 days p.i. compared to Pb group. Therefore, GsMTx4 treatment promoted a pulmonary anti-inflammatory response in the experimental MA-ALI mice.

Fig. 5
figure 5

Changes in pulmonary inflammation responses in the experimental MA-ALI mice upon GsMTx4 treatment. Total RNA was collected from lung tissues in mice across different groups (n = 4–5/group), and the mRNA expression of target genes was quantified using qPCR assay and 2−ΔΔCT method. The differences between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. The experiment was repeated three times with similar results. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment triggered pulmonary macrophage M2 polarization in the murine model of MA-ALI

As shown in Fig. 6, immunohistochemistry staining showed that only a few positively stained pulmonary CD68+, CD86+ and CD206+ macrophages were found in Naive and GsMTx4 groups. During P. berghei ANKA infection, three types of macrophages were commonly observed in the alveolar spaces, interstitial area and even alveoli in lung tissues. The animals in Pb group exhibited a remarkable elevation in positively stained CD68+, CD86+ and CD206+ macrophages in lung tissues compared to Naive group (P < 0.01). However, of the macrophages, M1-like subtype was the most prevalent in lung tissues of the infected mice in Pb group, with frequencies of ~ 64% and ~ 68% referring to positively stained CD68+ macrophages at 7 and 14 days p.i., respectively. In contrast, administration of GsMTx4 dramatically decreased the numbers of CD68+ macrophages (P < 0.05 and P < 0.01) and CD86+ macrophages (P < 0.01) and the ration of CD86+ macrophages/CD68+ macrophages (P < 0.05) while significantly elevating the number of pulmonary CD206+ macrophages (P < 0.05) and ration of CD206+ macrophages/CD68+ macrophages (P < 0.05) in Pb + GsMTx4 group related to those in Pb group at 7 and 14 days p.i., respectively. These findings suggest that blockage of Piezo1 with GsMTx4 promoted pulmonary macrophage polarization toward M2 phenotype during the process of MA-ALI.

Fig. 6
figure 6

Changes in pulmonary macrophage M1/M2 polarization in the experimental MA-ALI mice upon GsMTx4 treatment. A–C Representative figures of pulmonary CD68 (a marker of total macrophages), CD86 (a marker of M1-like macrophages) and CD206 (a marker of M2-like macrophages) in mice across different groups using immunohistochemical staining under a light microscope at 400 × magnification. The positively stained CD68+, CD86+ and CD206+ macrophages are illustrated by dark-brown staining (arrows). Naive mice a; GsMTx4-treated uninfected mice b; Plasmodium berghei ANKA-infected control mice at 7 days p.i. c; GsMTx4-treated infected mice at 7 days p.i. d; P. berghei ANKA-infected control mice at 14 days p.i. (e); GsMTx4-treated infected mice at 14 days p.i. f. D Positively stained cells/field was calculated from > 20 lung fields per animal (n = 4–5 mice/group). The differences in positively stained cells/field between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment reduced pulmonary ferroptosis in murine model of MA-ALI

To evaluate the effect of GsMTx4 treatment on pulmonary iron accumulation in the process of MA-ALI, Perl's Prussian blue staining was employed. As shown in Fig. 7, no obvious iron accumulation was observed in lung tissues in Naive and GsMTx4 groups, while P. berghei ANKA infection triggered higher levels of iron deposition in lung tissues in Pb group at 7 and 14 days p.i. than in Naive group (P < 0.01). Notably, the administration of GsMTx4 treatment dramatically reduced the level of pulmonary iron accumulation in Pb + GsMTx4 group compared to Pb group at 7 and 14 days p.i. (P < 0.01). Similarly, immunohistochemical staining of ferroptosis markers (e.g. GPX4 and 4-HNE) and Piezo1 was performed across different groups (Fig. 8), and the data revealed a higher expression of 4-HNE (an activator of ferroptosis, P < 0.01) but lower expression of GPX4 (an inhibitor of ferroptosis, P < 0.01) and Piezo1 (P < 0.05 and P < 0.01) in Pb + GsMTx4 group at 7 and 14 days p.i. compared to Pb group. Our results demonstrated that blockage of Piezo1 with GsMTx4 suppressed pulmonary ferroptosis during the MA-ALI process.

Fig. 7
figure 7

Changes in pulmonary iron accumulation in the experimental MA-ALI mice upon GsMTx4 treatment. A Representative figures of pulmonary iron accumulation in mice across different groups using Perl’s Prussian blue staining under light microscope at 400 × magnification. Naive mice a; GsMTx4-treated uninfected mice b; Plasmodium berghei ANKA-infected control mice at 7 days p.i. c; GsMTx4-treated infected mice at 7 days p.i. d; P. berghei ANKA-infected control mice at 14 days p.i. e; GsMTx4-treated infected mice at 14 days p.i. f. B IOD/area of positive Perl’s Prussian blue stained cells was calculated in > 20 lung fields per animal (n = 4–5 mice/group). The differences in IOD/area between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image
Fig. 8
figure 8

Changes in pulmonary Piezo1 and ferroptosis in the experimental MA-ALI mice upon GsMTx4 treatment. A–C Representative figures for pulmonary GPX4 (an inhibitor of ferroptosis), 4-HNE (an activator of ferroptosis) and Piezo1 in mice across different groups using immunohistochemical staining under a light microscope at 400 × and 200 × magnification. The positively stained GPX4, 4-HNE and Piezo1 cells are illustrated by dark-brown staining. Naive mice a; GsMTx4-treated uninfected mice b; Plasmodium berghei ANKA infected-control mice at 7 days p.i. c; GsMTx4-treated infected mice at 7 days p.i. d; P. berghei ANKA infected control mice at 14 days p.i. e; GsMTx4-treated infected mice at 14 days p.i. f. D IOD/area of positively stained GPX4, 4-HNE and Piezo1 cells was calculated in > 20 lung fields per animal (n = 4–5 mice/group). The differences in IOD/area between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment decreased Piezo1 and 4-HNE expression in CD68+ macrophages in murine model of MA-ALI

We studied the Piezo1 and 4-HNE expression on pulmonary CD68+ macrophages in the experimental MA-ALI mice upon GsMTx4 treatment. Immunofluorescence double staining showed that a few pulmonary CD68+-Piezo1+ macrophages and CD68+-4-HNE+ macrophages were found in Naive and GsMTx4 groups (Fig. 9). PbA-infected control mice exhibited a significant elevation in the number of pulmonary CD68+-Piezo1+ (P < 0.01) and CD68+-4-HNE+ macrophages (P < 0.01) at 7 and 14 days p.i. relative to naive mice, respectively. Notably, the number of pulmonary CD68+-Piezo1+ macrophages/field and CD68+-4-HNE+ macrophages/field was reduced by GsMTx4 treatment in Pb + GsMTx4 groups compared with Pb group (P < 0.01). Collectively, these results indicated that blockage of Piezo1 with GsMTx4 inhibited Piezo1 and ferroptosis expression in pulmonary CD68+ macrophages during the MA-ALI process.

Fig. 9
figure 9

Changes in pulmonary CD68+-Piezo1+ and CD68+-4-HNE+ macrophage number in the experimental MA-ALI mice upon GsMTx4 treatment. A Representative figures of pulmonary Piezo1 and 4-HNE expression in CD68+ macrophages in mice across different groups using immunofluorescence double staining under a fluorescence microscope at 200 × magnification. Positive expression of CD68+ macrophages is shown by green fluorescence and positive expression of Piezo1 and 4-HNE by red fluorescence. Co-expression of CD68+ macrophage and Piezo1 (or 4-HNE) was indicated by yellow fluorescence. B Number of CD68+-Piezo1+ macrophages/field and CD68+-4-HNE+ macrophages/field was counted from > 20 lung fields per animal (n = 4–5 mice/group). Differences in numbers of CD68+-Piezo1+ macrophages/field and CD68+-4-HNE+ macrophages/field between two groups and among multiple groups were analyzed by independent sample t-test and one-way ANOVA test, respectively. NS, P > 0.05 vs. naive mice; #P < 0.05 and ##P < 0.01 vs. naive mice; &P < 0.05 and &&P < 0.01 vs. infected control mice at 7 days p.i.; *P < 0.05 and **P < 0.01 vs. infected control mice at 14 days p.i. Data are expressed as mean ± SD; the experiments were performed with four to five mice per group

Full size image

GsMTx4 treatment led to higher mRNA levels of M2 polarization markers and GPX4 but a lower level of 4-HNE in the iRBC-stimulatd RAW264.7 cells in vitro

To explore the effects of GsMTx4 treatment on polarization and ferroptosis in iRBC-stimulated RAW264.7 cells in vitro, the mRNA levels of CD86, CD206, TNF-α, IL-1β, IL-4, IL-10, GPX-4 and 4-HNE in iRBC-stimulated RAW264.7 cells upon GsMTx4 treatment were measured using qPCR assay (Fig. 10). Compared with RAW264.7 cells in the blank group, mRNA levels of CD86 (P < 0.01), CD206 (P < 0.01), TNF-α (P < 0.01), IL-1β (P < 0.01), IL-4 (P < 0.01), IL-10 and 4-HNE (P < 0.05) were remarkably elevated but showed notably decreased mRNA levels of GPX4 (P < 0.01) in the iRBC-stimulated RAW264.7 cells at 24 and 48 h of co-culture. Notably, higher mRNA levels of CD206 (P < 0.05 or P < 0.01), IL-4 (P < 0.01), IL-10 (P < 0.01) and GPX4 (P < 0.05 or P < 0.001) but lower mRNA levels of CD86 (P < 0.01), TNF-α (P < 0.01), IL-1β (P < 0.05 or P < 0.01) and 4-HNE (P < 0.01) were observed in the iRBC-stimulated RAW264.7 cells with GsMTx4 treatment than in those with iRBC-stimulated RAW264.7 cells at 24 and 48 h of co-culture, respectively.

Fig. 10
figure 10

Changes in mRNA expression in CD86, CD206, TNF-α, IL-1β, IL-4, IL-10, GPX4 and 4-HNE in iRBC-stimulated RAW264.7 cells upon GsMTx4 treatment. RAW264.7 cells were pretreated with Piezo1 inhibitor GsMTx4 (5 μM) for 1 h followed by co-culture with 5.0 × 106 iRBC/well for 24 h and 48 h, respectively. Total RNA was collected from RAW264.7 cells across different groups, and the mRNA expression of target genes was quantified by using qPCR assay and 2−ΔΔCT method. The differences between two groups and among multiple groups are analyzed by independent sample t-test and one-way ANOVA test, respectively. #P < 0.05 and ##P < 0.01 vs. RAW264.7 cells co-cultured only with PBS for 24 h; &P < 0.05 and &&P < 0.01 vs. RAW264.7 cell co-cultured with iRBCs for 24 h; *P < 0.05 and **P < 0.01 vs. RAW264.7 cell co-cultured only with PBS for 48 h; §P < 0.05 and §§P < 0.01 vs. RAW264.7 cell co-cultured with iRBCs for 48 h. Data are expressed as mean ± SD; the experiment was repeated five times with similar results

Full size image

Discussion

As reported, sequestrations of iRBCs on lung postcapillary venules were documented as a pivotal factor in the pathological process of MA-ALI by partly triggering impaired blood flow and subsequent excessive pro-inflammatory responses [7, 26]. Accumulated studies have shown that the mechanosensitive Piezo1 channel was highly distributed in the organs (e.g. lung) and numerous immune cells (e.g. macrophages) and recently served as a key determinant of vascular blood flow sensitivity and subsequent lung pathology [20, 22]. A previous study further indicated that perivascular macrophages precisely regulated blood flow through the release of iNOS-produced NO following ischemic injury [22]. Thus, it is reasonably hypothesized that Piezo1 in macrophages could potentially mediate the pathogenesis of MA-ALI by sensing impaired pulmonary blood flow, but its functional role and underlying mechanism were less well understood. In the present study, our findings showed that P. berghei ANKA-infected mice exhibited higher levels of protein concentrations in BALF, lung wet/dry weight ratio, pulmonary vascular leakage and pathological score in lung tissue than navie mice, indicating successful establishment of the MA-ALI murine model. Our data were similar to those in a previous report [24] where P. berghei ANKA induced ALI in female Kunming mice; the model was successfully constructed with characterization by dyspnea or respiratory insufficiency occurring at 5–7 days p.i. before death. Compared with naive mice, elevated expression of Piezo1 and number of CD68+-Piezo1+ macrophages was observed in the lung tissue of experimental MA-ALI mice, followed by a rapid increase in lung pathological injury in the present study, indicating that the activity of Piezo1 could mediate the severity of murine MA-AIL mice. However, not all results were well understood. Previous studies demonstrated that upregulation of Piezo1 was associated with an increase in lung vascular hyperpermeability, pulmonary hypertension and ARDS-associated pulmonary fibrosis [27,28,29]. To further assess whether blockage of Piezo1 could improve the severity in experimental MA-ALI mice, these animals were treated with Piezo1 inhibitor GsMTx4 in the present study. Strikingly, treatment with GsMTx4 dramatically alleviated lung pathological damage and apoptosis, coinciding with a longer survival time and higher expression of anti-inflammatory cytokines (e.g. IL-4 and IL-10) but lower expression of pro-inflammatory cytokines (e.g. TNF-a and IL-1β) compared with the infected control mice. Our data were consistent with those in the previous report [11] where mice lacking Piezo1 exhibited a decreased pulmonary inflammation response in the context of fibrotic autoinflammation or bacterial infection. Additionally, pharmacological inhibition of Piezo1 with GsMTx4 alleviated lung pathological changes, water content and protein leakage in the process of MV-exacerbated ARDS-associated pulmonary fibrosis [30]. Further studies identified Piezo1 as a mediator of macrophage proliferation and polarization and demonstrated that activity of the Piezo1 channel was strongly involved in the process of macrophage-mediated inflammatory diseases [21, 31]. The data in the present study also showed that blockage of Piezo1 with GsMTx4 dramatically decreased the number of CD68+ and CD86+ macrophages (M1-like macrophages) in lung tissue but triggered a remarkable increase of CD206+ macrophages (M2-like macrophages) in the process of MA-ALI. Additionally, an in vitro study showed that administration of GsMTx4 led to a dramatic increase in the mRNA levels of CD206 and anti-inflammatory cytokines (e.g. IL-4 and IL-10) in iRBC-stimulated RAW264.7 cells but triggered lower mRNA levels of CD68 and pro-inflammatory cytokines (e.g. TNF-α and IL-1β). Our data were consistent with a previous report where the activated Piezo1 contrarily triggered M1 macrophage polarization in response to LPS, triggered overproduction of proinflammatory cytokines (e.g. TNF-α and IL-1β) and ultimately contributed to collagen degradation in periodontitis [32]. It was reported that the excessive pulmonary pro-inflammatory responses were strongly correlated with the pathogenesis of MA-ALI [24], while contrarily anti-inflammatory cytokines (e.g. IL-4 and IL-10) effectively improved uncontrolled pro-inflammatory response-driven lung pathogenesis [33]. Thus, our data indicated that blockage of Piezo1 with GsMTx4 could attenuate the severity of MA-ALI by promoting the pulmonary macrophages' polarization of M1 to M2 phenotype and triggering an elevated level of anti-inflammatory responses for lung tissue repair.

Apoptosis is a well-recognized form of programmed cell death that plays a pivotal role in maintaining cellular homeostasis by eliminating damaged or dysfunctional cells. Contrarily, dysfunction or dysregulation of cell apoptosis led to pathological conditions in numerous lung diseases [34]. The accumulated evidence showed that MA-ALI was partly characterized by excessive and uncontrolled inflammation and apoptosis in lung tissue [35, 36]. A substantial increase in apoptosis or apoptotic biomarkers (e.g. TNF, FAS, Bax, Bad, FAS/FASL and caspases-3/8) was commonly observed in leukocytes, alveolar cells and endothelial cells of lung tissue from severe P. falciparum malaria patients with pulmonary edema and experimental MA-ALI mice [35, 36]. An in vitro study also showed that apoptosis was detected in human primary pulmonary endothelial cells co-cultured with P. falciparum field isolates [37]. Further study demonstrated that apoptosis in endothelial cells contributed to the pathogenesis of MA-ALI, primarily as a facilitator of the alveolar-capillary barrier disruption [36]. The present study found that a dramatic elevation of apoptotic cells was observed in lung tissue of experimental MA-ALI mice compared to naive mice, while increased levels of apoptotic cells were suppressed by GsMTx4 treatment. A previous study indicated that Piezo1 mediated Ca2+-dependent cell death, including apoptosis and ferroptosis, in response to mechanical stimuli [38]. Our data were like those in other reports where activation of Piezo1 contrarily triggered intensive apoptosis of type II pneumocytes during ARDS [39]. Thus, our findings suggested that intervention of Piezo1 with GsMTx4 could attenuate lung injury in experimental MA-ALI mice via suppression of excessive pulmonary apoptosis. As reported above, intervention of Piezo1 with GsMTx4 dramatically promoted pulmonary macrophage polarization of M1 to M2, followed by a decrease of apoptosis and inflammatory responses in lung tissue of experimental MA-ALI mice in the present study. Similarly, it was reported that M1-like macrophages triggered an elevated level of apoptosis in bone marrow mesenchymal stem cells by delivering exosomal miR-222 to BMSCs [40], while M2-like macrophages contrarily suppressed the levels of apoptosis and inflammation in human umbilical vein endothelial cells by exosomal miR-221-3p overexpression [41]. Thus, our data indicated that intervention with Piezo1 with GsMTx4 could attenuate inflammatory responses and apoptosis in a murine model of MA-ALI by promoting macrophages M2 polarization.

Iron is an essential metal for several vital cellular processes, including DNA synthesis, cellular respiration, cell growth and death, while iron overload in organs is linked to a variety of lung diseases [42]. The previous study demonstrated that iron could prevent the ECM process by attenuating the accumulation of T cells in the brain [43]; however, another study indicated that iron overload in trophoblasts of P. berghei-infected placenta was related to fetal death [44], indicating a controversial role of iron overload in regulating malaria disease severity. Ferroptosis is a newly emerging type of cell death that is mainly triggered by excessive intracellular iron accumulation and massive lipid peroxidation, downregulation of system Xc− activity, inhibition of glutathione peroxidase 4 (GPX4) and an increase of lipid ROS and 4-HNE [45]. Emerging evidence has demonstrated that defective or excessive ferroptosis is involved in the pathological process of lung diseases [46]. A previous study revealed that ferroptosis contributed to neuron damage in ECM pathogenesis and activated CD8+T cells acted as key inducers of neuronal ferroptosis [47]. Notably, high levels of HO-1 (an activator of ferroptosis), which could induce iron overload and cell death in the context of certain inflammatory conditions [48], were detected in severe malaria patients with ALI [49]. In the present study, a dramatic increase in levels of intracellular iron accumulation and 4-HNE (an activator of ferroptosis) but decreased levels of GPX4 (an inhibitor of ferroptosis) were observed in lung tissue of experimental MA-ALI mice compared to naive mice, which were rescued by administration of the Piezo1 inhibitor GsMTx4, indicating that ferroptosis could be involved in mediating the severity of MA-ALI. Similarly, Piezo1 channel mediated ionizing radiation-induced pulmonary endothelial cell ferroptosis [50]. Previous studies demonstrated that Piezo1 was robustly expressed in macrophages and functioned as a key regulator of macrophage phagocyte activity, iron overload and subsequent cell ferroptosis [51]. Our data also demonstrated that the level of ferroptosis in CD68+ macrophages (or the number of CD68+-4-HNE+ macrophages/field) was decreased by administration of the Piezo1 inhibitor (GsMTx4), followed by a decline in the number of M1-like macrophages and improved lung injury in experimental MA-ALI mice. Our finding was similar to those of other previous reports, where uridine alleviated sepsis-induced acute lung injury by inhibiting ferroptosis of macrophages [52]; activated ferroptosis in macrophages contrarily accelerated the occurrence of sepsis [53]. Moreover, a previous study demonstrated that ferroptosis was triggered by increasing M1-like macrophages in neutrophilic airway inflammation, whereas quercetin decreased the level of ferroptosis in lung tissues by suppressing the pro-inflammatory M1-like macrophages [54]. Thus, our raw data suggested that blockage of Piezo1 with GsMTx4 could suppress macrophage ferroptosis and M1 polarization, in turn improving the severity of MA-ALI.

This study has several limitations: (i) Our limited facilities did not allow us to directly determine the change in pulmonary blood flow during P. berghei ANKA infection and identify the link between the activity of Piezo1 and change in pulmonary blood flow; (ii) Piezo1-depleted or KO mice were not suited to exploring the function of Piezo1 in the severity of MA-ALI; (iii) the present study did not accurately elucidate how Piezo1 exclusively targeted macrophage ferroptosis or M1/M2 polarization in the process of MA-ALI. Thus, further in-depth investigations without these limitations could be useful to better understand the role of Piezo1 or Piezo1 macrophages in the pathogenesis of MA-ALI.

Conclusions

In summary, we identified the function of mechanosensitive Piezo1 channel in mediating the severity of experimental MA-ALI. Results from the present study showed a dramatically increased expression of Piezo1 and number of CD68+-Piezo1+ macrophages in lung tissues of the experimental MA-ALI mice followed by a substantial increase in lung pathological injury. The data further showed the blockage of Piezo1 with GsMTx4 alleviated lung injury in experimental MA-ALI mice, partly by promoting macrophage polarization of M1 to M2 subtypes and subsequent anti-inflammatory responses, but alternatively inhibited apoptosis and ferroptosis in lung tissues. Although the exclusive mechanism underlying Piezo1 mediates macrophage functions (e.g. M1/M2 polarization, apoptosis and ferroptosis) and its potential role in severity of MA-ALI requires further investigation, our findings suggest that inhibition of Piezo1 channel in macrophages could be a potential therapeutic target for treating MA-ALI.

Availability of data and materials

All datasets generated for this study are included in the manuscript and additional file.

References

  1. WHO. World Malaria Report. Geneva: World Health Organization; 2022. p. 2022.

    Google Scholar 

  2. Van den Steen PE, Deroost K, Deckers J, Van Herck E, Struyf S, Opdenakker G. Pathogenesis of malaria-associated acute respiratory distress syndrome. Trends Parasitol. 2013;29:346–58.

    Article  PubMed  Google Scholar 

  3. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis. 2008;45:179–93.

    PubMed  Google Scholar 

  4. Lovegrove FE, Gharib SA, Peña-Castillo L, Patel SN, Ruzinski JT, Hughes TR, et al. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 2008;4:e1000068.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Klinkhamhom A, Glaharn S, Srisook C, Ampawong S, Krudsood S, Ward SA, et al. M1 macrophage features in severe Plasmodium falciparum malaria patients with pulmonary oedema. Malar J. 2020;19:182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhong M, Komarova Y, Rehman J, Malik AB. Mechanosensing Piezo channels in tissue homeostasis including their role in lungs. Pulm Circ. 2018;8:2045894018767393.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mukherjee D, Chora ÂF, Lone JC, Ramiro RS, Blankenhaus B, Serre K, et al. Host lung microbiota promotes malaria-associated acute respiratory distress syndrome. Nat Commun. 2022;13:3747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ma S, Cahalan S, LaMonte G, Grubaugh ND, Zeng W, Murthy SE, et al. Common PIEZO1 allele in African populations causes RBC dehydration and attenuates Plasmodium infection. Cell. 2018;173:443–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nguetse CN, Purington N, Ebel ER, Shakya B, Tetard M, Kremsner PG, et al. A common polymorphism in the mechanosensitive ion channel PIEZO1 is associated with protection from severe malaria in humans. Proc Natl Acad Sci USA. 2020;117:9074–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lohia R, Allegrini B, Berry L, Guizouarn H, Cerdan R, Abkarian M, et al. Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion. Cell Mol Life Sci. 2023;80:124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Solis AG, Bielecki P, Steach HR, Sharma L, Harman CCD, Yun S, et al. Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. Nature. 2019;573:69–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Aykut B, Chen R, Kim JI, Wu D, Shadaloey SAA, Abengozar R, et al. Targeting Piezo1 unleashes innate immunity against cancer and infectious disease. Sci Immunol. 2020. https://doi.org/10.1126/sciimmunol.abb5168.

    Article  PubMed  Google Scholar 

  13. Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease. Immunity. 2022;55:1564–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hou F, Xiao K, Tang L, Xie L. Diversity of macrophages in lung homeostasis and diseases. Front Immunol. 2021;12:753940.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lagassé HA, Anidi IU, Craig JM, Limjunyawong N, Poupore AK, Mitzner W, et al. Recruited monocytes modulate malaria-induced lung injury through CD36-mediated clearance of sequestered infected erythrocytes. J Leukoc Biol. 2016;99:659–71.

    Article  PubMed  Google Scholar 

  16. Besnard AG, Guabiraba R, Niedbala W, Palomo J, Reverchon F, Shaw TN, et al. IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS Pathog. 2015;11:e1004607.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mei X, Ye Z, Chang Y, Huang S, Song J, Lu F. Trichinella spiralis co-infection exacerbates Plasmodium berghei malaria-induced hepatopathy. Parasit Vectors. 2020;13:440.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cahayani WA, Norahmawati E, Budiarti N, Fitri LE. Increased CD11b and hypoxia-inducible factors-1alpha expressions in the lung tissue and surfactant protein-D levels in serum are related with acute lung injury in severe malaria of C57BL/6 mice. Iran J Parasitol. 2016;11:303–15.

    PubMed  PubMed Central  Google Scholar 

  19. Lagasse HAD, Scott A. Lung macrophages control malaria-induced pulmonary inflammation. J Immunol. 2011;186:56.

    Article  Google Scholar 

  20. Atcha H, Jairaman A, Holt JR, Meli VS, Nagalla RR, Veerasubramanian PK, et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nat Commun. 2021;12:3256.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Tang Y, Zhao C, Zhuang Y, Zhong A, Wang M, Zhang W, et al. Mechanosensitive Piezo1 protein as a novel regulator in macrophages and macrophage-mediated inflammatory diseases. Front Immunol. 2023;14:1149336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Vågesjö E, Parv K, Ahl D, Seignez C, Herrera Hidalgo C, Giraud A, et al. Perivascular macrophages regulate blood flow following tissue damage. Circ Res. 2021;128:1694–707.

    Article  PubMed  Google Scholar 

  23. Galvão-Filho B, de Castro JT, Figueiredo MM, Rosmaninho CG, Antonelli LRDV, Gazzinelli RT. The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4. Mucosal Immunol. 2019;12:312–22.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Liu J, Huang S, Su XZ, Song J, Lu F. Blockage of galectin-receptor interactions by α-lactose exacerbates Plasmodium berghei-induced pulmonary immunopathology. Sci Rep. 2016;6:32024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhang X, Zhang M, Wang QR, Hou X, Zhou T, Liu J, et al. Malaria-derived exosomes exacerbate liver injury during blood stage of Plasmodium berghei infection. Acta Trop. 2023;239:106815.

    Article  CAS  PubMed  Google Scholar 

  26. Dondorp AM, Kager PA, Vreeken J, White NJ. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol Today. 2000;16:228–32.

    Article  CAS  PubMed  Google Scholar 

  27. Friedrich EE, Hong Z, Xiong S, Zhong M, Di A, Rehman J, et al. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions. Proc Natl Acad Sci USA. 2019;116:12980–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chen J, Miao J, Zhou D, Liao J, Wang Z, Lin Z, et al. Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension. Thromb Res. 2022;218:52–63.

    Article  CAS  PubMed  Google Scholar 

  29. Fang XZ, Li M, Wang YX, Zhang P, Sun MM, Xu JX, et al. Mechanosensitive ion channel Piezo1 mediates mechanical ventilation-exacerbated ARDS-associated pulmonary fibrosis. J Adv Res. 2023;53:175–86.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang Y, Jiang L, Huang T, Lu D, Song Y, Wang L, et al. Mechanosensitive cation channel Piezo1 contributes to ventilator-induced lung injury by activating RhoA/ROCK1 in rats. Respir Res. 2021;22:250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Xu H, Guan J, Jin Z, Yin C, Wu S, Sun W, et al. Mechanical force modulates macrophage proliferation via Piezo1-AKT-Cyclin D1 axis. FASEB J. 2022;36:e22423.

    Article  CAS  PubMed  Google Scholar 

  32. Zhao T, Chu Z, Chu CH, Dong S, Li G, Wu J, et al. Macrophages induce gingival destruction via Piezo1-mediated MMPs-degrading collagens in periodontitis. Front Immunol. 2023;14:1194662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Perez-Mazliah D, Langhorne J. CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol. 2015;5:671.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sauler M, Bazan IS, Lee PJ. Cell death in the lung: the apoptosis-necroptosis axis. Annu Rev Physiol. 2019;81:375–402.

    Article  CAS  PubMed  Google Scholar 

  35. Punsawad C, Viriyavejakul P, Setthapramote C, Palipoch S. Enhanced expression of Fas and FasL modulates apoptosis in the lungs of severe P. falciparum malaria patients with pulmonary edema. Int J Clin Exp Pathol. 2015;8:10002–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Sercundes MK, Ortolan LS, da Silva JV, Bella LM, de Castro QT, Debone D, et al. Blockade of caspase cascade overcomes malaria-associated acute respiratory distress syndrome in mice. Cell Death Dis. 2022;13:144.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Essone JCBB, N’Dilimabaka N, Ondzaga J, Lekana-Douki JB, Mba DN, Deloron P, et al. Comparison of apoptosis in human primary pulmonary endothelial cells and a brain microvascular endothelial cell line co-cultured with Plasmodium falciparum field isolates. BMC Infect Dis. 2017;17:454.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kim YJ, Hyun J. Mechanosensitive ion channels in apoptosis and ferroptosis: focusing on the role of Piezo1. BMB Rep. 2023;56:145–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Liang GP, Xu J, Cao LL, Zeng YH, Chen BX, Yang J, et al. Piezo1 induced apoptosis of type II pneumocytes during ARDS. Respir Res. 2019;20:118.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Qi Y, Zhu T, Zhang T, Wang X, Li W, Chen D, et al. M1 macrophage-derived exosomes transfer miR-222 to induce bone marrow mesenchymal stem cell apoptosis. Lab Invest. 2021;101:1318–26.

    Article  CAS  PubMed  Google Scholar 

  41. Cheng X, Zhou H, Zhou Y, Song C. M2 Macrophage-derived exosomes inhibit apoptosis of HUVEC cell through regulating miR-221-3p expression. Biomed Res Int. 2022;2022:1609244.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Brown AC, Horvat JC. Casting iron in the pathogenesis of fibrotic lung disease. Am J Respir Cell Mol Biol. 2021;65:130–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Van Den Ham KM, Shio MT, Rainone A, Fournier S, Krawczyk CM, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451.

    Article  PubMed  Google Scholar 

  44. Penha-Gonçalves C, Gozzelino R, de Moraes LV. Iron overload in Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death. Front Pharmacol. 2014;5:155.

    PubMed  PubMed Central  Google Scholar 

  45. Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Xu W, Deng H, Hu S, Zhang Y, Zheng L, Liu M, et al. Role of ferroptosis in lung diseases. J Inflamm Res. 2021;14:2079–90.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Liang J, Shen Y, Wang Y, Huang Y, Wang J, Zhu Q, et al. Ferroptosis participates in neuron damage in experimental cerebral malaria and is partially induced by activated CD8+ T cells. Mol Brain. 2022;15:57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17:2703–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Pereira MLM, Ortolan LS, Sercundes MK, Debone D, Murillo O, Lima FA, et al. Association of heme oxygenase 1 with lung protection in malaria-associated ALI/ARDS. Mediators Inflamm. 2016;2016:4158698.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Guo XW, Zhang H, Huang JQ, Wang SN, Lu Y, Cheng B, et al. PIEZO1 ion channel mediates ionizing radiation-induced pulmonary endothelial cell ferroptosis via Ca2+/Calpain/VE-Cadherin signaling. Front Mol Biosci. 2021;8:725274.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ma J, Zhang H, Chen Y, Liu X, Tian J, Shen W. The Role of macrophage iron overload and ferroptosis in atherosclerosis. Biomolecules. 2022;12:1702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Lai K, Song C, Gao M, Deng Y, Lu Z, Li N, et al. Uridine alleviates sepsis-induced acute lung injury by inhibiting ferroptosis of macrophage. Int J Mol Sci. 2023;24:5093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Liu H, Li L. Ferroptosis in macrophage impairment in sepsis. Appl Bionics Biomech. 2022;2022:5792866.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Wang Y, Wan R, Peng W, Zhao X, Bai W, Hu C. Quercetin alleviates ferroptosis accompanied by reducing M1 macrophage polarization during neutrophilic airway inflammation. Eur J Pharmacol. 2023;938:175407.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was financially in part supported by Science Foundation of Traditional Chinese Medicine Bureau of Guangdong Province (No. 20231207) and Guangdong Provincial Medicine Science Foundation (no. A2023240). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou, 510006, People’s Republic of China

    Min Zhang, Qian Ru Wang, Xinpeng Hou, Tingting Zhou, Lirong Wu, Jie Wang, Xiaobao Jin & Bo Huang

  2. Guangzhou Chest Hospital, Guangzhou, 510095, People’s Republic of China

    Qi Wang

  3. Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, 511400, People’s Republic of China

    Xiaoyan Yang

  4. School of Basic Medical Science, Guangdong Pharmaceutical University, Guangzhou, 510006, People’s Republic of China

    Xiaobo Liu & Bo Huang

  5. Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada

    Zhenlong Liu

Authors
  1. Min Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qian Ru Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinpeng Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoyan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tingting Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaobo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lirong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiaobao Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zhenlong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Bo Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MZ, QRW, XH, QW, XY, TZ, XL, LW, JW and XJ performed experiments and analyzed the data. MZ wrote the first draft of the manuscript. BH and ZL conceived and designed the experiments, analyzed data and revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhenlong Liu or Bo Huang.

Ethics declarations

Ethics approval and consent to participate

All animal procedures were reviewed and approved by the Animal Ethics Committee of Guangdong Pharmaceutical University (no. gdpulac2023001).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Sequences of target gene primers for qPCR assay.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, M., Wang, Q.R., Hou, X. et al. Blockage of mechanosensitive Piezo1 channel alleviates the severity of experimental malaria-associated acute lung injury. Parasites Vectors 17, 46 (2024). https://doi.org/10.1186/s13071-024-06144-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-024-06144-5

Keywords

Parasites & Vectors

ISSN: 1756-3305

Contact us